Opinion: The Trump administration should rescind the NIH ‘access planning’ rule
The government already struggles to find licensees for many of its inventions, and adding more red tape in the form of the NIH access-planning rule will only make the problem…
At the start of the year, the National Institutes of Health finalized a policy that will require anyone seeking to license certain NIH-owned patents to submit an “access plan” detailing how they plan to make their products available to underserved groups.
Those who don’t comply with agreed-upon access plans risk having their patent licenses terminated.
